Inversago Pharma
Presence
Novo Nordisk is one of the...
Novo Nordisk is a company listed under the stock ticker NOVO (DK).
Novo Nordisk has a direct presence in 11 countries.Novo Nordisk has 16 subsidiaries including Cardior Pharmaceuticals, Dicerna Pharmaceuticals and Inversago Pharma.
They are in:
- Pharmaceuticals71%
- Biotechnology12%
- Other18%
Acquisition, funding and merger involving Novo Nordisk.
- Novo Nordisk has announced the acquisition of Inversago Pharma (posted on August 15 2023).
Executives
View the org chart displaying its 15 main executives
Most searched biographies at Inversago Pharma
- François Ravenelle, Chief Executive Officer and Director
- Jamie Stiff, Director
- Carlo Incerti, Chairman of the Board
Create your alert
to follow the executive moves at Inversago Pharma.
Biotechnology
Novo Nordisk has 2,291 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Bruker has announced the acquisition of NanoString Technologies (posted on May 13 2024).
- Aardvark Therapeutics has just announced a $85 Million fundraising (posted on May 12 2024).
- Bluejay Therapeutics has just announced a $182 Million fundraising (posted on May 12 2024).
Popular contacts in Biotechnology
News
Press releases by Inversago Pharma
- News Details
- News & Events – Page 3 – Inversago Pharma
- News & Events – Inversago Pharma
- News & Events – Page 2 – Inversago Pharma
Social media about Inversago Pharma
- Inversago Pharma on Wikipedia, Google News & Yahoo Finance
- Inversago Pharma on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including François Ravenelle 
Call Inversago Pharma at +1 438...
